Matches in SemOpenAlex for { <https://semopenalex.org/work/W1966892932> ?p ?o ?g. }
Showing items 1 to 92 of
92
with 100 items per page.
- W1966892932 endingPage "241" @default.
- W1966892932 startingPage "235" @default.
- W1966892932 abstract "The binding to human serum albumin (HSA) of two drugs which are chemically related to theophylline, 1-methyl-3-pro-pylxanthine (MPX), a new bronchodilator, and 3-propylxanthine (enprofylline), was investigated in vitro using an ultrafiltration method. The binding process involves one class of binding sites, with n = 2 and Kd1 = 0.403 mM and n = 1 and Kd1 = 0.906 mM for MPX and enprofylline, respectively. The binding of both drugs to HSA was shown to be dependent on pH with approximately 20% of MPX and 60% of enprofylline unbound at pH 6.60 and 10% and 40%, respectively, unbound at pH 7.45. Albumin concentration also had a significant effect on the binding of both drugs. Elevation of free fatty acid concentrations in the HSA solution resulted in an increase in the free fraction of both drugs. A study using oleic acid as a representative inhibitor revealed that the inhibitory effect of free fatty acid on MPX binding is due to competition for binding sites. These results suggest that free fatty acid may play a role in the decreased binding of MPX. The findings indicate that factors such as these that affect the protein binding of both drugs could be of importance when using the drugs with asthmatic patients in various disease states. Correspondence: T. Hasegawa, Department of Hospital Pharmacy, Nagoya University School of Medicine, Tsurumai- cho, Showa-ku, Nagoya 466, Japan." @default.
- W1966892932 created "2016-06-24" @default.
- W1966892932 creator A5018690037 @default.
- W1966892932 creator A5019058402 @default.
- W1966892932 creator A5034279515 @default.
- W1966892932 creator A5038252807 @default.
- W1966892932 creator A5046811190 @default.
- W1966892932 creator A5063951742 @default.
- W1966892932 creator A5090940067 @default.
- W1966892932 date "1989-12-01" @default.
- W1966892932 modified "2023-10-14" @default.
- W1966892932 title "Protein binding characteristics of new bronchodilators, 1-methyl-3-propylxanthine (MPX) and 3-propylxanthine (enprofylline)" @default.
- W1966892932 cites W1519693306 @default.
- W1966892932 cites W1602784471 @default.
- W1966892932 cites W1970976721 @default.
- W1966892932 cites W1974265700 @default.
- W1966892932 cites W1990195252 @default.
- W1966892932 cites W1990922336 @default.
- W1966892932 cites W1999387516 @default.
- W1966892932 cites W2000101010 @default.
- W1966892932 cites W2010395725 @default.
- W1966892932 cites W2012024558 @default.
- W1966892932 cites W2012197537 @default.
- W1966892932 cites W2025954408 @default.
- W1966892932 cites W2063024612 @default.
- W1966892932 cites W2066413524 @default.
- W1966892932 cites W2075393704 @default.
- W1966892932 cites W2087526401 @default.
- W1966892932 cites W2109139768 @default.
- W1966892932 cites W2233492637 @default.
- W1966892932 cites W2336612646 @default.
- W1966892932 cites W2394660565 @default.
- W1966892932 doi "https://doi.org/10.1016/0378-5173(89)90020-3" @default.
- W1966892932 hasPublicationYear "1989" @default.
- W1966892932 type Work @default.
- W1966892932 sameAs 1966892932 @default.
- W1966892932 citedByCount "7" @default.
- W1966892932 crossrefType "journal-article" @default.
- W1966892932 hasAuthorship W1966892932A5018690037 @default.
- W1966892932 hasAuthorship W1966892932A5019058402 @default.
- W1966892932 hasAuthorship W1966892932A5034279515 @default.
- W1966892932 hasAuthorship W1966892932A5038252807 @default.
- W1966892932 hasAuthorship W1966892932A5046811190 @default.
- W1966892932 hasAuthorship W1966892932A5063951742 @default.
- W1966892932 hasAuthorship W1966892932A5090940067 @default.
- W1966892932 hasConcept C107824862 @default.
- W1966892932 hasConcept C126322002 @default.
- W1966892932 hasConcept C185592680 @default.
- W1966892932 hasConcept C2776042228 @default.
- W1966892932 hasConcept C2776125364 @default.
- W1966892932 hasConcept C2778095195 @default.
- W1966892932 hasConcept C2778597219 @default.
- W1966892932 hasConcept C2781018748 @default.
- W1966892932 hasConcept C2781403372 @default.
- W1966892932 hasConcept C43617362 @default.
- W1966892932 hasConcept C55493867 @default.
- W1966892932 hasConcept C71924100 @default.
- W1966892932 hasConcept C98274493 @default.
- W1966892932 hasConceptScore W1966892932C107824862 @default.
- W1966892932 hasConceptScore W1966892932C126322002 @default.
- W1966892932 hasConceptScore W1966892932C185592680 @default.
- W1966892932 hasConceptScore W1966892932C2776042228 @default.
- W1966892932 hasConceptScore W1966892932C2776125364 @default.
- W1966892932 hasConceptScore W1966892932C2778095195 @default.
- W1966892932 hasConceptScore W1966892932C2778597219 @default.
- W1966892932 hasConceptScore W1966892932C2781018748 @default.
- W1966892932 hasConceptScore W1966892932C2781403372 @default.
- W1966892932 hasConceptScore W1966892932C43617362 @default.
- W1966892932 hasConceptScore W1966892932C55493867 @default.
- W1966892932 hasConceptScore W1966892932C71924100 @default.
- W1966892932 hasConceptScore W1966892932C98274493 @default.
- W1966892932 hasIssue "3" @default.
- W1966892932 hasLocation W19668929321 @default.
- W1966892932 hasOpenAccess W1966892932 @default.
- W1966892932 hasPrimaryLocation W19668929321 @default.
- W1966892932 hasRelatedWork W2014198551 @default.
- W1966892932 hasRelatedWork W2031476979 @default.
- W1966892932 hasRelatedWork W2055905370 @default.
- W1966892932 hasRelatedWork W2084365251 @default.
- W1966892932 hasRelatedWork W2094037280 @default.
- W1966892932 hasRelatedWork W2115732671 @default.
- W1966892932 hasRelatedWork W2164754849 @default.
- W1966892932 hasRelatedWork W2318675864 @default.
- W1966892932 hasRelatedWork W2426732143 @default.
- W1966892932 hasRelatedWork W2760564672 @default.
- W1966892932 hasVolume "56" @default.
- W1966892932 isParatext "false" @default.
- W1966892932 isRetracted "false" @default.
- W1966892932 magId "1966892932" @default.
- W1966892932 workType "article" @default.